This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Walter E. Rizzoni, MD; Harvey I. Pass, MD; Margaret N. Wesley, PhD; Steven A. Rosenberg, MD, PhD; Jack A. Roth, MD

Arch Surg. 1986;121(11):1248-1252.

Abstract
• Survival benefit and prognostic factors useful for patient selection have not been previously analyzed for patients with recurrent pulmonary metastases from soft-tissue sarcomas. Twenty-nine patients in our study had two or more resections of pulmonary metastases from 1976 to 1983. There were no operative deaths and three complications for 40 operations (7.5%). Factors predictive of increased survival following the second resection of pulmonary metastases were resectability and a disease-free interval of greater than six months from the first thoracotomy to the second recurrence in the lung. The tumor doubling time of the first recurrence and the presence of three or fewer nodules on full-lung tomography before the first thoracotomy, which were predictors of survival following initial resection, also predicted survival following subsequent resections. Overall median survival following the second resection was 14.5 months (22% overall three-year survival). The postresection actuarial survival curves for patients undergoing 1,2, or 3 or more resections were not significantly different. Our findings demonstrate that patients undergoing repeated resections of pulmonary metastases from soft-tissue sarcomas can achieve prolonged survival.

(Arch Surg 1986;121:1248-1252)

Author Affiliations
From the Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md. Dr Roth is now with M. D. Anderson Hospital, Houston.

Footnotes
Accepted for publication Aug 12, 1986.

Read before the 39th Annual Meeting of the Society of Surgical Oncology, Washington, DC, May 12, 1986.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gould et al.
Chest 2007;132:108S-130S.
ABSTRACT | FULL TEXT  

Accuracy of Helical CT in the Detection of Pulmonary Metastases: Is Intraoperative Palpation Still Necessary?
Parsons et al.
Ann. Thorac. Surg. 2004;78:1910-1918.
ABSTRACT | FULL TEXT  

Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial
Burt et al.
Ann. Thorac. Surg. 2000;69:1542-1549.
ABSTRACT | FULL TEXT  

Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies
Temeck et al.
Ann. Thorac. Surg. 1998;66:908-913.
ABSTRACT | FULL TEXT  

Long-Term Results After Repeated Surgical Removal of Pulmonary Metastases
Kandioler et al.
Ann. Thorac. Surg. 1998;65:909-912.
ABSTRACT | FULL TEXT  

Isolated Lung Perfusion With Doxorubicin Prolongs Survival in a Rodent Model of Pulmonary Metastases
Abolhoda et al.
Ann. Thorac. Surg. 1997;64:181-184.
ABSTRACT | FULL TEXT  

LONG-TERM RESULTS OF LUNG METASTASECTOMY: PROGNOSTIC ANALYSES BASED ON 5206 CASES
The International Registry of Lung Metastases et al.
J. Thorac. Cardiovasc. Surg. 1997;113:37-49.
ABSTRACT | FULL TEXT  

Surgical Resection of Pulmonary Metastases From Colorectal Adenocarcinoma: Special Reference to Repeated Pulmonary Resections
Mori et al.
Arch Surg 1991;126:1297-1302.
ABSTRACT